
An Ohio State hematologist discusses a new trial comparing tovorafenib plus rituximab with standard cladribine-based treatment, and what quality of life means for patients.
After my post last week about the first drug approved to treat cancer in dogs, I heard about a bulldog named Cash who's undergoing chemotherapy. For anyone living in the Dallas area, there's a fundraiser this Saturday at






